Everything below concerns research chemical. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-07-29. Where a claim depends on a specific study, the study is described rather than over-claimed.
The four residues give epitalon a molecular formula of C14H22N4O9 and a molecular weight near 390.35 daltons. The presence of two acidic residues, glutamate and aspartate, makes the free peptide strongly acidic, while the alanine and glycine ends provide neutral, nonpolar character. This combination produces a molecule with substantial water solubility. Because there are no cysteine, methionine, or tryptophan residues, the peptide lacks the most common oxidation-sensitive side chains, which simplifies handling compared with many longer peptides.
The proposed relationship between epitalon and pineal function is a central part of its background. Khavinson's group reported that short peptides corresponding to regions of larger pineal proteins could influence gene expression in cells. Epitalon was framed as a synthetic analogue of an active fragment rather than a direct isolation product. Whether the tetrapeptide reproduces the effects of the parent extract is an open question, because comparative studies are limited and the parent extract itself is not a single defined substance.
Interest in epitalon is usually discussed within the broader field of short peptide bioregulators, a category that includes other synthetic di-, tri-, and tetrapeptides studied by the same research group. These compounds share a common rationale: that small fragments of tissue-derived proteins can retain biological activity and can be produced reproducibly. The category as a whole remains outside mainstream pharmacological consensus, and epitalon specifically has a limited presence in independent, non-Russian research literature, which shapes how its evidence base is described.
Freeze-dried epitalon is normally kept at minus twenty degrees Celsius in a sealed, desiccated container, protected from light. Short excursions at ambient temperature during shipping are generally tolerated, but repeated warming and cooling cycles encourage moisture uptake, which shortens shelf life. Once dissolved, the peptide is far less stable than the solid: aqueous solutions are subject to hydrolysis and to deamidation at the aspartate and glutamate residues. Working solutions are therefore held refrigerated and used within days, and repeated freezing and thawing of the same vial is best avoided.
Identity and purity are checked by reversed-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, where the peptide bond absorbs. Mass spectrometry confirms the expected mass and reveals whether truncation products or adducts are present. Acid hydrolysis followed by amino acid analysis gives the residue ratio, which should approximate one alanine, one glutamate, one aspartate and one glycine. Counter-ions such as acetate or trifluoroacetate remain in the dried product and lower net peptide content, so a stated purity figure on a label does not by itself describe how much peptide a vial holds.
| Property | Value | Notes |
|---|---|---|
| Amino acid sequence | Ala-Glu-Asp-Gly | Tetrapeptide, often abbreviated AEDG |
| Molecular formula | C14H22N4O9 | Free peptide, unmodified termini |
| Molecular weight | ~390.35 Da | Calculated for the free acid form |
| Appearance | White to off-white powder | Typical lyophilized product form |
| Solubility class | Freely soluble in water | Two acidic residues dominate ionic character |
Reported biological findings come mainly from cell culture and rodent experiments. Those studies describe changes in telomerase catalytic subunit expression, melatonin rhythm amplitude, and antioxidant enzyme activity after peptide exposure. Human data are sparse and consist of small trials with limited blinding and inconsistent endpoints. The proposed mechanisms remain hypotheses rather than established facts, and there is no consensus on whether effects observed in animals carry over to people. Independent replication outside the original research groups is limited, which is a recognised gap in the published literature.
The parent extract epithalamin was characterised as a low-molecular-weight fraction of pineal tissue rather than a single defined chemical entity. Researchers fractionated it and tested successive fragments for activity, a screening approach typical of peptide discovery work in that era. Epitalon emerged from that process as one of the shorter sequences of interest. Because the original extract was never fully resolved into individual components, claims about which constituent drives a given effect rest on inference. This distinction matters when reading older reports that attribute extract observations to the tetrapeptide itself.
Epitalon is a synthetic tetrapeptide with the residue sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. Its monoisotopic mass is approximately 390.35 daltons, and it is usually supplied as a lyophilised trifluoroacetate or acetate salt. The compound was derived from a pineal gland extract called epithalamin, a heterogeneous preparation investigated in the former Soviet Union. Researchers associated with the Saint Petersburg Institute of Bioregulation and Gerontology described the tetrapeptide as a constituent fragment of that extract. Commercial material is offered as a laboratory reagent rather than as a finished pharmaceutical product.
Reference material is normally supplied as a lyophilised powder in a sealed vial. Product literature typically recommends storage at minus twenty degrees Celsius or colder, protected from light and moisture. Freeze-thaw cycling is usually avoided because repeated condensation can introduce water into the vial. Working solutions are commonly prepared fresh, aliquoted, and kept cold for short periods rather than stored at ambient temperature. Labelling the date of opening helps track how long a vial has been in use.
Solubility is high in water, phosphate-buffered saline and normal saline, a pattern that follows from the two acidic residues in the chain. The peptide dissolves poorly in non-polar solvents such as hexane or chloroform. Stock solutions are often prepared in water first and then diluted into the buffer of interest. Because the molecule is small and hydrophilic, filtration through a low-protein-binding membrane is usually straightforward, and visible particulates are uncommon in freshly made solutions.
The compound is described in the literature as a derivative of epithalamin, a preparation obtained from bovine pineal tissue. Work on this peptide family was carried out mainly by a research group in Saint Petersburg beginning in the 1980s, and the substance was later registered for clinical use in Russia under the name Epitalon. Outside that region it is generally treated as a research chemical rather than an approved medicine. Statements about its biological activity rest on a relatively small number of studies, and independent replication remains limited.
In its supplied form epitalon is a white to off-white powder, usually lyophilized and often hygroscopic. It dissolves readily in water and in aqueous buffers, and it is commonly handled as the acetate or trifluoroacetate salt to improve stability during purification and drying. The amide backbone is labile in aqueous media, so solutions are less durable than the dry solid. Handling notes in the chemical literature therefore emphasize keeping the powder dry, cool and shielded from light until it is dissolved.
Regulatory status varies by country and is not harmonized. Epitalon is not an approved drug in major Western jurisdictions. In some countries it is sold as a research chemical, and in others it has appeared in products marketed for other categories. This inconsistent status means that purity, labeling accuracy, and documentation differ widely between suppliers, and verification of identity and purity through independent analysis is the usual way buyers assess a given lot.
Epitalon appears in the literature primarily through a small number of research groups, most of them associated with the St. Petersburg Institute of Bioregulation and Gerontology. Publications describe cell culture experiments, animal studies, and a limited number of small human studies. Independent replication outside this network is sparse. As a result, reviews of the topic usually separate descriptive reports of observed effects from the question of whether those effects generalize, and they note the difficulty of comparing studies that use different preparations and endpoints.
Analytical characterization of epitalon relies on standard peptide methods. Reverse-phase high-performance liquid chromatography is used to assess purity, and mass spectrometry confirms identity by checking the observed mass against the expected value near 390 daltons. Amino acid analysis can verify composition. Because the peptide is short and hydrophilic, it elutes early on many reverse-phase columns, so method development often requires ion-pairing reagents to achieve adequate retention and resolution from related impurities.
=== Second week (28 February – 6 March) === On 28 February, clashes between Pakistan border guards and Afghan Taliban were reported along the border areas of Torkham. Later on, an airstrike was carried out by the PAF on Jalalabad Airport, the capital of Nangarhar province. An AFP journalist reported hearing sounds of two loud explosions from the direction of Jalalabad airport. Pakistan's media outlet also reported an airstrike in Nangarhar province targeting several Taliban headquarters. On the same day, Afghan forces claimed a Pakistani fighter was shot down over Jalalabad using anti-aircraft guns, with the pilot captured alive. Pakistan rejected the Afghan Taliban's claim, labeling it as wartime propaganda. Afterwards, the detained individual was severely beaten by the Afghan Taliban and locals, while being paraded through the market area in Jalalabad, with Taliban officials terming the event as an important war operation. However, later on, it was revealed that the pilot that Afghan forces captured was an ordinary Afghan national who was a parachutist and had no connection to the Pakistani army. Further investigation also revealed that news of downing a fighter jet was false, and the detained individual was later released.
==== Glands ==== There are two types of glands, with mucus-secreting esophageal glands being found in the submucosa and esophageal cardiac glands, similar to cardiac glands of the stomach, located in the lamina propria and most frequent in the terminal part of the organ. The mucus from the glands gives a good protection to the lining. The submucosa also contains the submucosal plexus, a network of nerve cells that is part of the enteric nervous system.
== External links == Allozyme Electrophoresis Techniques – a complete guide to starch gel electrophoresis Development of new isozyme specific therapeutics – Fatty Acid Dioxygenases and Eicosanoid Hormones (Estonia)
Sources: en.wikipedia.org
Finally, a civilization known as "Type III" reaches the milepost set in 5,800 years when humanity's rate of energy consumption is predicted by the author to match the power emitted by the approximated 1011 stars in the Milky Way galaxy, which involves harnessing power of up to an estimated 4×1037 W. Assuming the development of radio, Kardashev predicted that in the following two decades (i.e. in the 1980s) it would be possible to build antennas of 100,000 m2 capable of detecting Type II and III civilizations. A Type I civilization like that of Earth would be able to receive the extraordinary energetic emissions of the other types of civilizations, which would supposedly be able to emit continuously. Kardashev then examined the characteristics of a transmission from an artificial source. He mentioned the two cosmic radio sources discovered in 1963 by the California Institute of Technology, CTA-21 and CTA-102 in particular, which would have characteristics close to those of a presumed artificial source. The most suitable region of the galaxy for observing Type II and III civilizations would then be the Galactic Center, due to the high density of the stellar population it harbors. He then recommended that the search programs for such artificial sources should focus on other nearby galaxies, such as the Andromeda Galaxy, the Magellanic Clouds, M87, or Centaurus A. Kardashev concluded his paper by noting that the possible discovery of even the simplest organisms on Mars would increase the likelihood that Type II civilizations exist in the galaxy.
=== Genetically modified food === In 2015, Ayyadurai published a paper that applied systems biology, which uses mathematical modeling, to predict the chemical composition of genetically modified (GM) soybeans, and whether or not they were substantially equivalent to unmodified soybeans. The paper claimed that GM soybeans have lower levels of the antioxidant glutathione and higher levels of carcinogenic formaldehyde, making the modified soybean substantially different, contrary to previous safety assessments. Shortly after publication, Ayyadurai embarked on a speaking tour of the U.S. At the National Press Club, he said that genetic modification had "fundamentally modified the metabolic system of the soy", disrupting the "beautiful way of detoxifying [formaldehyde]" present in non-GM soy. The European Food Safety Agency evaluated the paper and determined that "the author's conclusions are not supported" due to the lack of information on the input into the model, the fact that the model was not validated and because no measurements of soybeans were made to establish whether GM soy actually contained elevated levels of formaldehyde. Plant scientist Kevin Folta noted that there was "no evidence ever published ... that shows a difference in formaldehyde between GM and non-GM varieties". Ayyadurai later cited the study as evidence of a lack of safety standards for GM foods and bet Monsanto a $10 million building if they could prove that they were safe.
== Early life == Margaret Ruth Kidder, one of five children, was born on October 17, 1948, in Yellowknife, Northwest Territories, the daughter of Jocelyn Mary "Jill" (née Wilson), a history teacher from British Columbia, and Kendall Kidder, an American explosives expert and engineer originally from New Mexico. She was of Welsh and English descent. Kidder was born in Yellowknife because of her father's employment, which required the family to live in remote locations. Her father subsequently served as the manager of the Yellowknife Telephone Company from 1948 to 1951. She had one sister, Annie, who is an actress and executive director of the People for Education charity, and three brothers: John, Michael, and Peter. Two of her siblings married notable Canadians: Annie married actor Eric Peterson and John married politician Elizabeth May. Kidder's niece Janet Kidder is also an actress. Recalling her childhood in northern Canada, Kidder said: "We didn't have movies in this little mining town. When I was 12, my mom took me to New York [City] and I saw Bye Bye Birdie, with people singing and dancing, and that was it. I knew I had to go far away. I was clueless, but I [have done] okay." In addition to Yellowknife, she also spent some time growing up in Labrador City, Newfoundland and Labrador. Kidder became interested in politics at a young age, which she credited to debates which her parents had over the dinner table; her mother had socialist leanings, while her father was a conservative Republican.
Sources: en.wikipedia.org
== Applications == Because many optically active chemicals such as tartaric acid, are stereoisomers, a polarimeter can be used to identify which isomer is present in a sample – if it rotates polarized light to the left, it is a levo-isomer, and to the right, a dextro-isomer. It can also be used to measure the ratio of enantiomers in solutions. The optical rotation is proportional to the concentration of the optically active substances in solution. Polarimetry may therefore be applied for concentration measurements of enantiomer-pure samples. With a known concentration of a sample, polarimetry may also be applied to determine the specific rotation (a physical property) when characterizing a new substance.
However, in a preprint study, Carnegie Mellon University researchers tested the behavior of agents in a simulated software company and found that none of the agents could complete a majority of the tasks assigned to them. Other researchers had similar findings with Devin AI and other agents in both formal business settings and freelance work. In June 2025, CNN argued that CEOs's statements on AI replacing their employees were a strategy to "[keep] workers working by making them afraid of losing their jobs." Tech companies have pressured employees to use generative AI models in their work, including AI coding agents. Brian Armstrong, the CEO of Coinbase, fired several employees who did not. Some business leaders have replaced some of their employees with agents, but have said that the agents would need more supervision than those employees. In October 2025, Futurism questioned whether Amazon's previously announced efforts to replace parts of its workforce with generative AI and AI agents could have led to the October 2025 outage of Amazon Web Services. Large technology companies such as Salesforce, Klarna and IBM announced layoffs in 2025, replacing hundreds of their employees in human resources or customer service with AI agents. However, Klarna later rehired several human employees. Yoshua Bengio warned at the 2025 World Economic Forum that "all of the catastrophic scenarios with AGI or superintelligence happen if we have agents". Financial authorities have warned that more complex and autonomous "agentic" AI could become a channel for systemic risk in finance.
An exclusive license outside of South Korea and China with Sanofi for Hanmi's Glucagon-like peptide-1 receptor agonist drug candidates for diabetes; Sanofi paid $434 million upfront and up to $3.2 billion in milestones and royalties over 10%. The deal included efpeglenatide, a long-acting glucagon-like peptide-1 receptor agonist; an insulin intended to be delivered once per week, and a fixed-dosed weekly GLP1-RA/insulin drug combination. An exclusive license outside of South Korea and China with the J&J subsidiary Janssen Pharmaceuticals for Hanmi's oxyntomodulin-analog metabolic disease programs, including HM12525A; J&J paid $105 million upfront and the deal included $810M in milestones and royalties higher than 10% An exclusive license in China with the Chinese company ZAI Labs for olmutinib. In April 2016 Hanmi announced that it had acquired land near Yantai in the Shandong province of China, where it would build a manufacturing plant and R&D facility; at that time it already had a facility in Beijing. In July Hanmi said it intended to invest more heavily in developing candidate substances of promising new drugs at an early stage in new pharmaceutical and biotech related fields, including through a venture capital firm set up by Sung-ki and colleagues. In May 2016 the Korean regulatory authority approved olmutinib as a second-line treatment for certain kinds of non-small cell lung cancer.
Sources: en.wikipedia.org
Epitalon is a synthetic tetrapeptide composed of four amino acids: alanine, glutamate, aspartate, and glycine. It is written as Ala-Glu-Asp-Gly. The free peptide has a molecular weight of about 390 daltons and is normally supplied as a lyophilized powder.
No. Epitalon is chemically synthesized, not extracted. It was designed as a short synthetic fragment conceptually related to larger pineal peptides studied in the same research tradition, particularly the extract known as epithalamin. The two are distinct materials with different compositions.
The term bioregulator is used in this research tradition for short peptides proposed to influence gene expression or cell function. Epitalon is grouped with other synthetic short peptides under this label. The term reflects a proposed mechanism rather than an established drug classification.
The solid is kept cold, dry and dark, typically at minus twenty degrees Celsius, in a sealed container with desiccant. Dissolved material is kept refrigerated and used promptly. Freezing and thawing a solution repeatedly is avoided because it accelerates degradation.